ReGelTec’s HYDRAFIL® System Gains CE Mark Approval for Chronic Low Back Pain Treatment
May 22, 2025
Breakthrough Injectable Gel Offers Minimally Invasive Relief for Patients with Degenerative Disc Disease Across Europe.
Breakthrough Injectable Gel Offers Minimally Invasive Relief for Patients with Degenerative Disc Disease Across Europe.
Auxilium Biotechnologies today announced enrollment of the first patient in a pivotal trial for its NeuroSpan Bridge implant for nerve regeneration.
Medtronic (NYSE: MDT)+
announced today that it received CE mark for several expanded indications for its Prevail balloon catheter